Oslo, Norway – 16 November 2022 – IDEX Biometrics ASA has acquired a volume production order from its accomplice IDEMIA, representing the most important order up to now for IDEX TrustedBio sensors. The order represents greater than USD 2 million in income for IDEX and can start delivery in Q1 2023. IDEX and IDEMIA are seeing market acceleration for biometric fee playing cards, and in early November the 2 corporations introduced a full-scale biometric card program by a significant financial institution within the UAE. IDEX Biometrics has additionally not too long ago confirmed agreements with issuers in Turkey and within the UK for biometric card packages, anticipated to succeed in markets within the first half of 2023.
”This order from our accomplice IDEMIA displays the growing demand for biometric fee playing cards powered by IDEX Biometrics TrustedBio expertise. IDEMIA has come to market with a superior answer which is gaining traction as banks start to launch large-scale biometric card packages globally”, feedback Vince Graziani, CEO of IDEX Biometrics.
For additional info contact:
Marianne Bøe, Head of Investor Relations
E-mail: [email protected]
Tel: + 47 918 00186
About IDEX Biometrics
IDEX Biometrics (OSE: IDEX and Nasdaq: IDBA) is a number one supplier of fingerprint identification applied sciences providing easy, safe, and private authentication for all. We assist folks make funds, show their id, achieve entry to info or unlock units with the contact of a finger. We invent, engineer, and commercialize these safe, but extremely user-friendly options. Our complete addressable market represents a quick rising multi-billion-unit alternative.
For extra info, go to www.idexbiometrics.com
TRADEMARK STATEMENT
IDEX, TrustedBio, IDEX Biometrics and the IDEX emblem are emblems owned by IDEX Biometrics ASA. All different manufacturers or product names are the property of their respective holders.
This info is topic to the disclosure necessities pursuant to Section 5-12 the Norwegian Securities Trading Act
